Welcome to Enabled Therapeutics, formerly known as Mercaptor. We are excited to share that all information on our website including our Capton intellectual property and approach is now managed by the founders of Enabled Therapeutics. This marks an exciting new phase in the development of Captons, and we look forward to advancing therapeutic solutions. All historical news below refers to Mercaptor, our former name.
Mercaptor Discoveries Sponsors Patient at Walk MS Event
In honor of Multiple Sclerosis Awareness Month and Week (March 10-16), Mercaptor Discoveries has sponsored a recently diagnosed MS patient, who will be walking at
Mercaptor at MS Breakthroughs Event
The MS Breakthroughs keynote speaker, Dr. Jeffrey Dunn Professor of Clinical Neurology Chief, Division of Neuroimmunology at Stanford University gave a brief educational update on
Mercaptor Team Member Spotlight: Sheana Nieh
Mercaptor Discoveries is made up of some pretty amazing people – smart, passionate pros who pursue science with the goal of helping millions who suffer
Dr. Todd Zankel on People Behind the Science
In this week’s episode of People Behind the Science, Dr. Todd Zankel, co-founder and Chief Science Officer at Mercaptor Discoveries discusses his career working in pharmaceutical and
Mercaptain Spotlight: Renée Kinkade
Mercaptor Discoveries is made up of some pretty amazing people – smart, passionate pros who pursue science with the goal of helping millions who suffer
Mercaptor Announces Publication of Patent Application Covering Foundational Technology
NOVATO, Calif., Nov. 21, 2018 /PRNewswire/ — Mercaptor Discoveries, a pharmaceutical company focused on developing unprecedented technology addressing significant unmet medical needs, today announced the publication of